Summary.-Chemotaxis of blood monocytes was measured in 31 patients with bronchial carcinoma and 19 cigarette smokers. Thirteen patients with metastatic bronchial carcinoma had significantly less (P < 0.005) chemotactic response than matched controls. Those with disease confined to the chest, or with recurrent or operable bronchial carcinoma, had no significant depression of monocyte chemotaxis. There was also no significant difference in monocyte chemotaxis between cigarette smokers and matched controls. These results support the concept that in human cancer there is a defect in monocyte chemotaxis, but in bronchial carcinoma significant depression was only apparent in those with advanced disease.
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THE role of cells of the mononuclear phagocytic series in immune surveillance has been suggested by a number of workers (Hibbs, Lambert and Remington, 1972; Alexander, 1976) . For example, aninhibitor of macrophage chemotaxis produced by various transplanted tumours in mice has been described (Snyderman and Pike, 1976) and in man the capacity of peripheral blood monocytes to respond by chemotaxis in vitro was depressed in patients with genito-urinary neoplasms (Hausman et al., 1975) , malignant melanoma (Rubin, Cosimi and Goetzl, 1976) and other human cancers (Boetcher and Leonard, 1974) . We have studied monocyte chemotaxis from 31 patients with bronchial carcinoma at various clinical stages, and also the monocyte chemotactic response of cigarette smokers who are known to be at risk for developing bronchial neoplasms.
PATIENTS AND CONTROLS
Patients w%ith bronchial carcinoma were classified according to the stage of their disease. Those with small tumours deemed suitable for surgical resection were termed operable. Disease which reappeared locally at the site of a surgical resection was termed recurrentt. Disease confined to the chest had spread locally from the primary site in the bronchus to involve surrounding lung, local lymph nodes and chest wall. The metastatic group had deposits of tumour outside the chest, commonly in liver or bone, as demonstrated clinically, or by radionuclide scanning.
Controls for the cancer groups were all convalescent, hospitalized patients who had sustained either myocardial infarctions or respiratory infections and in whom there was no evidence of malignant disease. Controls for cigarette smokers were all healthy, nonsmoking volunteers.
MATERIALS AND METHODS
Human peripheral-blood monocytes were separated on a Ficoll-Triosil gradient as previously described (Boyum, 1968) . Chemotaxis was quantified either by the "leading front" method using Millipore filters (Millipore Co., Wembley) of 8 jum pore size (Zigmond and Hirsch, 1973) or by the method of Snyderman et al., (1972) Nucleopore filters and polycarbonate Boyden chambers" Neuroprobe, Bethesda, Maryland, U.S.A.). The only modification was that the suspending medium for monocytes and for dilutions of chemoattractant was Medium 199 containing 30 mM Hepes buffer. The chemoattractant was either human serum in w%Nhich the complement system had been activated with purified cobra venom factor (CVF) (Ballow and Cochrane, 1969) or solutions of casein (British Drug Houses). Casein was used in the early part of the study, but its chemoattracting properties often deteriorated after a few days, even under a variety of storage conditions. The experiments with casein reported here are with freshly prepared material. In contrast, serum activated with CVF was divided into portions after preparation and stored at -80°C until use.
The chemotactic responses from patients with bronchial carcinoma or cigarette smokers were compared with age-and sex-matched controls and each pair was performed on the same day under the same experimental conditions. A three-point dose-response of chemoattractant was performed for each experiment. Optimal monocyte migration of cells, either from patients or smokers, was achieved with 0 5 mg/ml of fresh casein or 2.5% CVF-activated serum. Each assay was performed in duplicate, and measurements from each filter were the pooled results from 10 random high-power fields. The test and control samples were analysed by the Wilcoxon test of paired differences. The variation between duplicate filters was ± 15% as previously described (Turnbull and Kay, 1976; Turnbull, Evans and Kay, 1977) .
RESULTS

Bronchial carcinomia
The clinical staging and histology of the 31 patients with bronchial carcinoma are shown in Table I . Apart from one individual, all patients were male, and were matched with controls within 10 years of their age. The monocyte chemotactic response of patients with metastatic disease, and their respective controls, are shown in Table I , together with the histology and the treatment being received either at the time of sampling or before the chemotactic assay. There was a significantly greater depression in the (Tables II and III) . In a similar study on malignant melanoma (Rubin et al., 1976) , only patients with advanced disease had a monocyte defect.
The inhibitor of macrophage chemotaxis produced by various transplanted neoplasms in the peritoneal cavity of mice was partially identified as a protein of mol. wt. 6000-10,000 (Snyderman and Pike, 1976 Cigarette smokers showed no difference from controls in their monocyte migratory capacity, indicating that monocyte chemotaxis will not be useful in detecting individuals at risk for developing bronchial carcinoma (Table IV) . Studies with human alveolar macrophages obtained from smoking and non-smoking volunteers demonstrated both an increase in the number of cells recovered by bronchial lavage and of the chemotactic response of these cells from smokers when compared to controls (Warr and Martin, 1974) . This suggests that cigarette smoke probably has an initial non-specific "macrophageactivating effect" analogous to the influx of macrophages into tissues treated with various irritants such as mineral oil and glycogen.
The chemotactic activity of human serum activated with cobra venom factor is due almost entirely to the fragment cleaved from the 5th component of complement (C5a) liberated as a result of activation of the alternate pathway. When CVF-activated serum is placed on either side of the micropore chamber, migration is either minimal or absent, suggesting that this agent evokes chemotaxis, (i.e. directional migration) rather than random migration (Kay, unpublished).
There are difficulties in employing the chemotactic assay for clinical studies. The reasons include possible deterioration of the chemoattractant during storage, variations in an individual's cell response with time, and failure to reproduce this biological assay exactly on each occasion. In the present study these difficulties were largely overcome by matching each patient or smoker with a control individual for age and sex, withdrawing blood from each pair at the same time and performing the test under identical conditions. Comparison of these matched pairs by the Wilcoxon test of paired differences allowed statistical analysis.
Thus the present study suggests that defects in monocyte chemotaxis are only apparent at advanced stages of bronchial carcinoma, and not in those with relatively confined disease or in those individuals who are at risk for developing bronchial neoplasms.
